Literature DB >> 7065754

Multiple primary carcinomas of the colon and associated extracolonic primary malignant tumors.

T K Lee, M Barringer, R T Myers, J M Sterchi.   

Abstract

A review of 308 cases of colorectal carcinoma showed 12 cases (3.9%) of colorectal multiple primary malignant tumors and 14 cases (4.5%) of colorectal primary malignant tumor associated with extracolonic primary malignant tumor. A total of 60 tumors was involved: 14 each in the sigmoid and transverse colon; eight in the cecum; six in the rectum; one each in the ascending and descending colons; three each in the bladder and prostate; two each in the breast, cervix, and lung; and one each in the skin, nasopharynx, kidney, and endometrium. Three of the four patients with multifocal cancer were found to have in situ cancer, and 12.7% of concomitant adenomas had malignant changes. Seven patients had regional lymph node metastases. Of the six patients with rectocolonic multiple tumors who had adequate follow-up data, survival in three ranged from 19.5 to 60 months; three were alive and well 15 to 51 months after resection. Survival of patients with primary rectocolonic and extracolonic tumors was similar. From these data and the pathologic study of the resected specimens, we recommend for any patient with cancer of the rectocolon that the entire colon be searched for multiple primary malignant tumors, that extracolonic tumors be considered second primary tumors unless proved to be metastases, and that follow-up be long and include frequent rectocolonic examinations for a second primary tumor.

Entities:  

Mesh:

Year:  1982        PMID: 7065754      PMCID: PMC1352535          DOI: 10.1097/00000658-198204000-00020

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  32 in total

1.  Prevention of recurrent cancer of the large bowel.

Authors:  H Ellis
Journal:  Proc R Soc Med       Date:  1974-09

2.  Mutiple carcinomas of the colon and rectum.

Authors:  G R Ekelund; B Pihl
Journal:  Cancer       Date:  1974-06       Impact factor: 6.860

3.  Multiple adenocarcinomas of the colon and rectum.

Authors:  C R Travieso; L F Knoepp; P H Hanley
Journal:  Dis Colon Rectum       Date:  1972 Jan-Feb       Impact factor: 4.585

4.  A family study of adenocarcinoma of the colon and multiple primary cancer.

Authors:  H T Lynch; M Swartz; J Lynch; A J Krush
Journal:  Surg Gynecol Obstet       Date:  1972-05

5.  The significance of multiple adenocarcinomas of the colon and rectum.

Authors:  J E Devitt; L A Roth-Moyo; F N Brown
Journal:  Ann Surg       Date:  1969-03       Impact factor: 12.969

6.  Multiple primary malignant tumors.

Authors:  S I Hajdu; E O Hajdu
Journal:  J Am Geriatr Soc       Date:  1968-01       Impact factor: 5.562

7.  The lesion of the second cancer of the large bowel.

Authors:  R J Heald; H E Lockhart-Mummery
Journal:  Br J Surg       Date:  1972-01       Impact factor: 6.939

8.  Multiple malignant tumors of the colon and rectum.

Authors:  D Hojman; R A Garriz; I Markman
Journal:  Dis Colon Rectum       Date:  1966 Mar-Apr       Impact factor: 4.585

9.  Primary multiple malignancy of the colon and rectum: report of 230 cases.

Authors:  M Diamante; H E Bacon
Journal:  Dis Colon Rectum       Date:  1966 Nov-Dec       Impact factor: 4.585

10.  Incidence of multiple primary cancers per man-year of follow up: 20-year review from the Ellis Fischel State Cancer Hospital.

Authors:  J S Spratt; M G Hoag
Journal:  Ann Surg       Date:  1966-11       Impact factor: 12.969

View more
  12 in total

1.  A comparison of multiple synchronous colorectal cancer in ulcerative colitis, familial polyposis coli, and de novo cancer.

Authors:  A J Greenstein; G Slater; T M Heimann; D B Sachar; A H Aufses
Journal:  Ann Surg       Date:  1986-02       Impact factor: 12.969

2.  Double primary malignancy in colorectal cancer patients--MSI is the useful marker for predicting double primary tumors.

Authors:  H R Yun; L J Yi; Y K Cho; J H Park; Y B Cho; S H Yun; H C Kim; H K Chun; W Y Lee
Journal:  Int J Colorectal Dis       Date:  2008-09-17       Impact factor: 2.571

3.  Sacral chordoma developing two years after low anterior resection for rectal cancer.

Authors:  M Miyahara; T Saito; K Nakashima; K Hiratsuka; K Sato; K Kaketani; M Kobayashi; M Nakamura; S Yokoyama
Journal:  Surg Today       Date:  1993       Impact factor: 2.549

4.  Survival in colorectal carcinoma associated with previous extracolonic cancer.

Authors:  P P Varty; P Delrio; P B Boulos
Journal:  Ann R Coll Surg Engl       Date:  1994-05       Impact factor: 1.891

5.  Multiple colorectal carcinomas and colorectal carcinoma associated with extracolonic malignancies.

Authors:  H Maruyama; Y Hasuike; J Furukawa; M Naoi; N Takata; E Yayoi; J Okamura; S Okamoto
Journal:  Surg Today       Date:  1992       Impact factor: 2.549

6.  Colorectal carcinoma: importance of clinical and pathological factors in survival.

Authors:  G T Deans; C C Patterson; T G Parks; R A Spence; M Heatley; R J Moorehead; B J Rowlands
Journal:  Ann R Coll Surg Engl       Date:  1994-01       Impact factor: 1.891

7.  Synchronous breast and rectal cancers in a man.

Authors:  Anastasios J Karayiannakis; Stylianos Kakolyris; Georgios Kouklakis; Leonidas Chelis; Helen Bolanaki; Christos Tsalikidis; Constantinos Simopoulos
Journal:  Case Rep Oncol       Date:  2011-05-25

8.  Synchronous early primary adenocarcinoma of both rectum and gallbladder. Report of a case.

Authors:  Timothy Sakellaridis; Stavros Mathioulakis; Christos Antiochos
Journal:  Int Semin Surg Oncol       Date:  2005-09-14

9.  Colorectal cancer in cases of multiple primary cancers: Clinical features of 59 cases and point mutation analyses.

Authors:  Anshan Wu; Siqi He; Jingjing Li; Ling Liu; Chunlan Liu; Qi Wang; Xiaowei Peng; Jianda Zhou; Pei-Guo Cao; Ke Cao
Journal:  Oncol Lett       Date:  2017-04-26       Impact factor: 2.967

10.  Synchronous triple carcinoma of the colon and rectum.

Authors:  Chien-Chih Yeh; Sheng-Chuan Hsi; Chih-Pin Chuu; Yung-Hsi Kao
Journal:  World J Surg Oncol       Date:  2013-03-13       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.